February 4, 2021
Unique, collaborative real-world research consortium will study up to 12,000 NSCLC patients in the community setting over five years MYLUNG to deepen understanding of barriers and address challenges to improve care for lung cancer patients, including those with targetable mutations The MYLUNG consortium – or “Molecularly Informed Lung Cancer Treatment in a Community Cancer Network: […]
Read MoreDecember 2, 2020
Top researchers to present the latest clinical findings advancing treatment options for blood cancers and other hematologic diseases THE WOODLANDS, Texas, Dec. 2, 2020 — During the 62nd American Society of Hematology (ASH) Annual Meeting and Exposition, principal investigators from The US Oncology Network (The Network) and US Oncology Research will share detailed results from […]
Read MoreNovember 11, 2020
Community-based practices in The Network advance value-based care by significantly reducing costs while enhancing care THE WOODLANDS, TEXAS, Nov. 11, 2020—The US Oncology Network (The Network) reached a major milestone recently in its journey to provide high-quality, value-based care to local communities by enrolling its 100,000th patient in the Centers for Medicare & Medicaid Innovation’s […]
Read MoreOctober 22, 2020
By uniting with The Network, Alliance Cancer Specialists and Northwest Oncology strengthen their ability to deliver advanced cancer care in local communities THE WOODLANDS, Texas, Oct. 22, 2020— The US Oncology Network (The Network), the largest organization of its kind dedicated to advancing local cancer care and better patient outcomes, continues to expand its reach […]
Read MoreOctober 6, 2020
Chief Scientific Officer of US Oncology Research honored for groundbreaking achievements in gynecologic oncology THE WOODLANDS, Texas, Oct. 6, 2020 — Robert L. Coleman, MD, FACOG, FACS, chief scientific officer of US Oncology Research, has been named an inductee to the 2020 class of the OncLive® Giants of Cancer Care®. Now in its eighth year, […]
Read MoreSeptember 30, 2020
Inclusion of the CRESTONE Study within the Selected Trials for Accelerated Rollout Program will enhance patient recruitment and facilitate local site participation for patients with tumors harboring an NRG1 Gene Fusion NEW YORK, NY and THE WOODLANDS, Texas, Sept. 30, 2020—Elevation Oncology, a clinical stage biopharmaceutical company focused on the development of precision medicines for […]
Read MoreSeptember 29, 2020
Available in patients’ own communities, novel clinical trials are making an impact in the fight against cancer THE WOODLANDS, Texas, Sept. 29, 2020 — US Oncology Research, one of the largest community-based oncology research programs in the U.S. one of the largest community-based oncology research programs in the U.S. one of the largest community-based oncology […]
Read MoreAugust 4, 2020
A recognized leader in radiation oncology, Dr. Kavadi brings extensive experience in patient care, research and operations to The Network THE WOODLANDS, Texas, Aug. 4, 2020 — Vivek S. Kavadi, MD, FASTRO, a nationally known expert in the field of radiation oncology, has been named chief radiation oncology officer for The US Oncology Network (The Network). […]
Read MoreMay 28, 2020
Leading oncology researchers will present abstracts on latest clinical and real-world evidence research across a range of cancer types THE WOODLANDS, Texas, May 28, 2020 — During the virtual scientific program of the 2020 American Society of Clinical Oncology (ASCO) Annual Meeting, principal investigators from US Oncology Research and McKesson will demonstrate detailed results from more than 70 studies. Data […]
Read MoreMarch 31, 2020
Dr. Coleman brings extensive expertise in cancer research and program development to The Network THE WOODLANDS, Texas, March 31, 2020—The US Oncology Network (The Network) has named prominent cancer researcher Robert L. Coleman, MD, FACOG, FACS, as its new Chief Scientific Officer. In this role, Dr. Coleman will be the senior-most clinician scientist on The […]
Read More
